Molibresib
cas: 1260907-17-2 — see every product listed under this CAS number, including other names
Molibresib (CAS 1260907-17-2) is a chemical reagent available from Chemat. Available pack sizes: 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 100mg, 200mg. Offered by: TargetMol.
| brand | TargetMol |
|---|---|
| catalog number | T1906-1mg |
| cas | 1260907-17-2 |
| size | 1mg |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| TargetMol | 1mg | 425.84 Pln | |
| TargetMol | 2mg | 525.34 Pln | |
| TargetMol | 5mg | 731.05 Pln | |
| TargetMol | 10mg | 997.13 Pln | |
| TargetMol | 25mg | 1634.39 Pln | |
| TargetMol | 50mg | 2577.43 Pln | |
| TargetMol | 100mg | 3746.30 Pln | |
| TargetMol | 200mg | 5194.11 Pln | |
| TargetMol | 500mg | 7956.68 Pln |
properties
| purity | No data |
|---|---|
| delivery time | approx. 15 days |
Molibresib is a member of the class of triazolobenzodiazepine that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine substituted by methyl, 2-(ethylamino)-2-oxoethyl, 4-chlorophenyl, and methoxy groups at positions 1, 4S, 6, and 8, respectively. It is an orally bioavailable inhibitor of BET family of proteins that has demonstrated antitumour activity in preclinical models of solid and hematologic malignancies. It has a role as a bromodomain-containing protein 4 inhibitor, an antineoplastic agent and an apoptosis inducer. It is a secondary carboxamide, a triazolobenzodiazepine, an aromatic ether and a member of monochlorobenzenes.
Source: ChEBI
| Molecular formula | C22H22ClN5O2 |
|---|---|
| Molecular weight | 423.9 g/mol |
| IUPAC name | 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide |
| InChIKey | AAAQFGUYHFJNHI-SFHVURJKSA-N |
| SMILES | CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C |
Computed by PubChem (NCBI)